WAT(Waters Corporation) 的财务报表:医疗保健,诊断与研究。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $2.79B | $2.97B | $2.96B | $2.96B | $3.17B |
| 毛利润 | $1.63B | $1.72B | $1.76B | $1.76B | $1.88B |
| 营业利润 | $821.71M | $873.39M | $817.68M | $826.35M | $802.59M |
| 净利润 | $692.84M | $707.75M | $642.23M | $637.83M | $642.63M |
| 经营现金流 | $747.27M | $611.66M | $602.81M | $762.12M | $652.55M |
| 自由现金流 | — | — | $442.18M | $619.64M | $539.81M |
| 摊薄每股收益 | $11.17 | $11.73 | $10.84 | $10.71 | $10.76 |